Effects of Various Direct-acting Antivirals in the Quality of Life of Patients with Chronic Hepatitis C

Cerik, Hatun; Esen, Şaban; ALTINTAŞ ÖNER, BETÜL; Celik, Merve; Ozdemir, Tugba; Bozkurt, İlkay; Tanyel, Esra

doi:10.4274/mjima.galenos.2021.2020.12

Effects of Various Direct-acting Antivirals in the Quality of Life of Patients with Chronic Hepatitis C

Atıf İçin Kopyala

Cerik H. O., Esen Ş., ALTINTAŞ ÖNER B., Celik M., Ozdemir T., Bozkurt İ., ...Daha Fazla

MEDITERRANEAN JOURNAL OF INFECTION MICROBES AND ANTIMICROBIALS, cilt.10, 2021 (ESCI)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 10
Basım Tarihi: 2021
Doi Numarası: 10.4274/mjima.galenos.2021.2020.12
Dergi Adı: MEDITERRANEAN JOURNAL OF INFECTION MICROBES AND ANTIMICROBIALS
Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus
Anahtar Kelimeler: Hepatitis C, direct-acting antiviral, SF-36, Beck-Anxiety Inventory, quality of life
Ondokuz Mayıs Üniversitesi Adresli: Evet

Özet

Introduction: Chronic hepatitis C is an infectious disease known to affect people worldwide. The disease is characterized by both hepatic and extrahepatic manifestations that impair the patient's overall quality of life (QoL). Potent and easy-to-use direct-acting antivirals (DAAs) have been recently introduced to treat chronic hepatitis C virus (HCV) infection. This study aimed to assess the QoL of patients with chronic HCV before and after DAAs treatment.